Lukas E. Schmidt, MSc RSci
Department of Medicine II (Clinical Division of Cardiology)
Position: PHD Student
ORCID: 0000-0001-7565-1455
lukas.schmidt@muv.ac.at
Keywords
Apolipoproteins; Atherosclerosis; Chromatography; Hypolipidemic Agents; Lipoproteins; Mass Spectrometry; Proteomics
Selected publications
- Schmidt, L.E. et al. (2026) “Integrative Proteomic and Lipidomic Analysis of Patients With Acute Myocardial Infarction Treated With PCSK9 Antibodies and Statins,” Circulation: Genomic and Precision Medicine, 19(2). Available at: https://doi.org/10.1161/circgen.125.005345.
- Yin, X. et al. (2025) “A Comparative Proteomics Study of Autopsy and Fresh-Frozen Coronary Artery Samples,” Journal of Proteome Research, 24(7), pp. 3154–3159. Available at: https://doi.org/10.1021/acs.jproteome.5c00152.
- d’Escamard, V. et al. (2024) “Integrative gene regulatory network analysis discloses key driver genes of fibromuscular dysplasia,” Nature Cardiovascular Research, 3(9), pp. 1098–1122. Available at: https://doi.org/10.1038/s44161-024-00533-w.
- Theofilatos, K. et al. (2023) “Proteomic Atlas of Atherosclerosis: The Contribution of Proteoglycans to Sex Differences, Plaque Phenotypes, and Outcomes,” Circulation Research, 133(7), pp. 542–558. Available at: https://doi.org/10.1161/circresaha.123.322590.
- Clarke, R. et al. (2023) ‘Apolipoprotein Proteomics for Residual Lipid-Related Risk in Coronary Heart Disease’, Circulation Research, 132(4), pp. 452–464. Available at: https://doi.org/10.1161/circresaha.122.321690.